Commit
·
25c3ff9
1
Parent(s):
627c291
docs: add SPEC_12 for narrative report synthesis
Browse filesDetailed spec for fixing issue #85 - reports output structured
metadata instead of synthesized prose narrative.
Key findings:
- Current `_generate_synthesis()` is string templating with NO LLM call
- Microsoft agent-framework shows custom aggregator pattern
- Need dedicated SynthesisAgent with LLM-based prose generation
Implementation plan:
1. Create SynthesisAgent (`src/agents/synthesis.py`)
2. Add synthesis prompts with few-shot examples
3. Update orchestrators to call SynthesisAgent
4. Add proper test coverage
References Microsoft agent-framework patterns:
- concurrent_custom_aggregator.py
- fan_out_fan_in_edges.py
docs/specs/SPEC_12_NARRATIVE_SYNTHESIS.md
ADDED
|
@@ -0,0 +1,469 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# SPEC_12: Narrative Report Synthesis
|
| 2 |
+
|
| 3 |
+
**Status**: Draft
|
| 4 |
+
**Priority**: P1 - Core deliverable
|
| 5 |
+
**Related Issues**: #85, #86
|
| 6 |
+
**Related Spec**: SPEC_11 (Sexual Health Focus)
|
| 7 |
+
|
| 8 |
+
## Problem Statement
|
| 9 |
+
|
| 10 |
+
DeepBoner's report generation outputs **structured metadata** instead of **synthesized prose**. The current implementation uses string templating with NO LLM call for narrative synthesis.
|
| 11 |
+
|
| 12 |
+
### Current Output (Actual)
|
| 13 |
+
|
| 14 |
+
```markdown
|
| 15 |
+
## Sexual Health Analysis
|
| 16 |
+
|
| 17 |
+
### Question
|
| 18 |
+
Testosterone therapy for hypoactive sexual desire disorder?
|
| 19 |
+
|
| 20 |
+
### Drug Candidates
|
| 21 |
+
- **Testosterone**
|
| 22 |
+
- **LibiGel**
|
| 23 |
+
- **Androgel**
|
| 24 |
+
|
| 25 |
+
### Key Findings
|
| 26 |
+
- Testosterone therapy improves sexual desire and activity in postmenopausal women with HSDD.
|
| 27 |
+
- Transdermal testosterone is a preferred formulation.
|
| 28 |
+
|
| 29 |
+
### Assessment
|
| 30 |
+
- **Mechanism Score**: 8/10
|
| 31 |
+
- **Clinical Evidence Score**: 9/10
|
| 32 |
+
- **Confidence**: 90%
|
| 33 |
+
|
| 34 |
+
### Reasoning
|
| 35 |
+
The evidence provides a clear understanding of the mechanism of action...
|
| 36 |
+
|
| 37 |
+
### Citations (33 sources)
|
| 38 |
+
1. [Title](url)...
|
| 39 |
+
```
|
| 40 |
+
|
| 41 |
+
### Expected Output (Professional Research Report)
|
| 42 |
+
|
| 43 |
+
```markdown
|
| 44 |
+
## Sexual Health Research Report: Testosterone Therapy for Hypoactive Sexual Desire Disorder
|
| 45 |
+
|
| 46 |
+
### Executive Summary
|
| 47 |
+
|
| 48 |
+
Testosterone therapy represents a well-established, evidence-based treatment for
|
| 49 |
+
hypoactive sexual desire disorder (HSDD) in postmenopausal women. Our analysis of
|
| 50 |
+
33 peer-reviewed sources reveals consistent findings across multiple randomized
|
| 51 |
+
controlled trials, with transdermal testosterone demonstrating the strongest
|
| 52 |
+
efficacy-safety profile.
|
| 53 |
+
|
| 54 |
+
### Background
|
| 55 |
+
|
| 56 |
+
Hypoactive sexual desire disorder affects an estimated 12% of postmenopausal women
|
| 57 |
+
and is characterized by persistent lack of sexual interest causing personal distress.
|
| 58 |
+
The International Society for the Study of Women's Sexual Health (ISSWSH) published
|
| 59 |
+
clinical guidelines in 2021 establishing testosterone as a recommended intervention...
|
| 60 |
+
|
| 61 |
+
### Evidence Synthesis
|
| 62 |
+
|
| 63 |
+
**Mechanism of Action**
|
| 64 |
+
|
| 65 |
+
Testosterone exerts its effects on sexual desire through multiple pathways. At the
|
| 66 |
+
hypothalamic level, testosterone modulates dopaminergic signaling that underlies
|
| 67 |
+
libido. Evidence from Smith et al. (2021) demonstrates that androgen receptor
|
| 68 |
+
activation in the central nervous system correlates with subjective measures of
|
| 69 |
+
sexual desire (r=0.67, p<0.001)...
|
| 70 |
+
|
| 71 |
+
**Clinical Trial Evidence**
|
| 72 |
+
|
| 73 |
+
A systematic review of 8 randomized controlled trials (N=3,035) demonstrated that
|
| 74 |
+
transdermal testosterone significantly improved:
|
| 75 |
+
- Satisfying sexual events: +2.1 per month (95% CI: 1.4-2.8)
|
| 76 |
+
- Sexual desire scores: +0.4 on validated scales (p<0.001)
|
| 77 |
+
|
| 78 |
+
The Global Consensus Position Statement (2019) and ISSWSH Guidelines (2021) both
|
| 79 |
+
recommend transdermal testosterone as first-line therapy...
|
| 80 |
+
|
| 81 |
+
### Recommendations
|
| 82 |
+
|
| 83 |
+
Based on this evidence synthesis:
|
| 84 |
+
1. **Transdermal testosterone** (300 μg/day) is recommended for postmenopausal
|
| 85 |
+
women with HSDD not primarily related to modifiable factors
|
| 86 |
+
2. **Duration**: Continue for 6 months to assess efficacy; discontinue if no benefit
|
| 87 |
+
3. **Monitoring**: Lipid profile and liver function at baseline and 3-6 months
|
| 88 |
+
|
| 89 |
+
### Limitations & Future Directions
|
| 90 |
+
|
| 91 |
+
- Long-term safety data beyond 24 months remains limited
|
| 92 |
+
- Efficacy in premenopausal women less well-established
|
| 93 |
+
- Head-to-head comparisons between formulations are needed
|
| 94 |
+
|
| 95 |
+
### References
|
| 96 |
+
|
| 97 |
+
1. Parish SJ et al. (2021). International Society for the Study of Women's Sexual
|
| 98 |
+
Health Clinical Practice Guideline for the Use of Systemic Testosterone for
|
| 99 |
+
Hypoactive Sexual Desire Disorder in Women. J Sex Med. https://pubmed.ncbi.nlm.nih.gov/33814355/
|
| 100 |
+
...
|
| 101 |
+
```
|
| 102 |
+
|
| 103 |
+
## Root Cause Analysis
|
| 104 |
+
|
| 105 |
+
### Current Implementation (`src/orchestrators/simple.py:448-505`)
|
| 106 |
+
|
| 107 |
+
```python
|
| 108 |
+
def _generate_synthesis(
|
| 109 |
+
self,
|
| 110 |
+
query: str,
|
| 111 |
+
evidence: list[Evidence],
|
| 112 |
+
assessment: JudgeAssessment,
|
| 113 |
+
) -> str:
|
| 114 |
+
# ❌ NO LLM CALL - Just string templating!
|
| 115 |
+
drug_list = "\n".join([f"- **{d}**" for d in assessment.details.drug_candidates])
|
| 116 |
+
findings_list = "\n".join([f"- {f}" for f in assessment.details.key_findings])
|
| 117 |
+
|
| 118 |
+
return f"""{self.domain_config.report_title}
|
| 119 |
+
### Question
|
| 120 |
+
{query}
|
| 121 |
+
### Drug Candidates
|
| 122 |
+
{drug_list}
|
| 123 |
+
...
|
| 124 |
+
"""
|
| 125 |
+
```
|
| 126 |
+
|
| 127 |
+
**The problem**: No LLM is ever called to synthesize the report. It's just formatted
|
| 128 |
+
data from the JudgeAssessment.
|
| 129 |
+
|
| 130 |
+
### Microsoft Agent Framework Pattern
|
| 131 |
+
|
| 132 |
+
From `reference_repos/agent-framework/python/samples/getting_started/workflows/orchestration/concurrent_custom_aggregator.py`:
|
| 133 |
+
|
| 134 |
+
```python
|
| 135 |
+
# Define a custom aggregator callback that uses the chat client to SYNTHESIZE
|
| 136 |
+
async def summarize_results(results: list[Any]) -> str:
|
| 137 |
+
# Collect expert outputs
|
| 138 |
+
expert_sections: list[str] = []
|
| 139 |
+
for r in results:
|
| 140 |
+
messages = getattr(r.agent_run_response, "messages", [])
|
| 141 |
+
final_text = messages[-1].text if messages else "(no content)"
|
| 142 |
+
expert_sections.append(f"{r.executor_id}:\n{final_text}")
|
| 143 |
+
|
| 144 |
+
# Ask the MODEL to synthesize
|
| 145 |
+
system_msg = ChatMessage(
|
| 146 |
+
Role.SYSTEM,
|
| 147 |
+
text=(
|
| 148 |
+
"You are a helpful assistant that consolidates multiple domain expert outputs "
|
| 149 |
+
"into one cohesive, concise summary with clear takeaways."
|
| 150 |
+
),
|
| 151 |
+
)
|
| 152 |
+
user_msg = ChatMessage(Role.USER, text="\n\n".join(expert_sections))
|
| 153 |
+
|
| 154 |
+
# ✅ LLM CALL for synthesis
|
| 155 |
+
response = await chat_client.get_response([system_msg, user_msg])
|
| 156 |
+
return response.messages[-1].text
|
| 157 |
+
```
|
| 158 |
+
|
| 159 |
+
**The pattern**: The aggregator makes an **LLM call** to synthesize, not string concatenation.
|
| 160 |
+
|
| 161 |
+
## Solution Design
|
| 162 |
+
|
| 163 |
+
### Architecture
|
| 164 |
+
|
| 165 |
+
```
|
| 166 |
+
Current:
|
| 167 |
+
Evidence → Judge → {structured data} → String Template → Bullet Points
|
| 168 |
+
|
| 169 |
+
Proposed:
|
| 170 |
+
Evidence → Judge → {structured data} → SynthesisAgent → Narrative Prose
|
| 171 |
+
↓
|
| 172 |
+
LLM-based synthesis
|
| 173 |
+
```
|
| 174 |
+
|
| 175 |
+
### Components
|
| 176 |
+
|
| 177 |
+
#### 1. `SynthesisAgent` (`src/agents/synthesis.py`)
|
| 178 |
+
|
| 179 |
+
A new agent dedicated to narrative report generation:
|
| 180 |
+
|
| 181 |
+
```python
|
| 182 |
+
from pydantic import BaseModel
|
| 183 |
+
from pydantic_ai import Agent
|
| 184 |
+
|
| 185 |
+
class NarrativeReport(BaseModel):
|
| 186 |
+
"""Structured output for narrative report."""
|
| 187 |
+
executive_summary: str # 2-3 sentences, key takeaways
|
| 188 |
+
background: str # What is this condition, why does it matter
|
| 189 |
+
evidence_synthesis: str # Mechanism + Clinical evidence in prose
|
| 190 |
+
recommendations: list[str] # Actionable recommendations
|
| 191 |
+
limitations: str # Honest limitations
|
| 192 |
+
references: list[Reference] # Properly formatted
|
| 193 |
+
|
| 194 |
+
class SynthesisAgent:
|
| 195 |
+
"""Generates narrative research reports from structured data."""
|
| 196 |
+
|
| 197 |
+
async def synthesize(
|
| 198 |
+
self,
|
| 199 |
+
query: str,
|
| 200 |
+
evidence: list[Evidence],
|
| 201 |
+
assessment: JudgeAssessment,
|
| 202 |
+
domain: ResearchDomain,
|
| 203 |
+
) -> NarrativeReport:
|
| 204 |
+
"""Generate narrative prose report."""
|
| 205 |
+
# Build context
|
| 206 |
+
context = self._build_synthesis_context(evidence, assessment)
|
| 207 |
+
|
| 208 |
+
# ✅ LLM CALL for synthesis
|
| 209 |
+
result = await self.agent.run(
|
| 210 |
+
f"Generate a narrative research report for: {query}",
|
| 211 |
+
context=context,
|
| 212 |
+
)
|
| 213 |
+
return result.data
|
| 214 |
+
```
|
| 215 |
+
|
| 216 |
+
#### 2. Updated System Prompt (`src/prompts/synthesis.py`)
|
| 217 |
+
|
| 218 |
+
```python
|
| 219 |
+
SYNTHESIS_SYSTEM_PROMPT = """You are a scientific writer specializing in sexual health research.
|
| 220 |
+
Your task is to synthesize research evidence into a clear, narrative report.
|
| 221 |
+
|
| 222 |
+
## Writing Style
|
| 223 |
+
- Write in PROSE PARAGRAPHS, not bullet points
|
| 224 |
+
- Use academic but accessible language
|
| 225 |
+
- Be specific about evidence strength (e.g., "in a randomized controlled trial of N=200")
|
| 226 |
+
- Reference specific studies by author name
|
| 227 |
+
- Provide quantitative results where available
|
| 228 |
+
|
| 229 |
+
## Report Structure
|
| 230 |
+
|
| 231 |
+
### Executive Summary (REQUIRED - 2-3 sentences)
|
| 232 |
+
Summarize the key finding and clinical implication. Start with the bottom line.
|
| 233 |
+
Example: "Testosterone therapy demonstrates consistent efficacy for HSDD in
|
| 234 |
+
postmenopausal women, with transdermal formulations showing the best safety profile."
|
| 235 |
+
|
| 236 |
+
### Background (REQUIRED - 1 paragraph)
|
| 237 |
+
Explain the condition, its prevalence, and why this question matters clinically.
|
| 238 |
+
|
| 239 |
+
### Evidence Synthesis (REQUIRED - 2-4 paragraphs)
|
| 240 |
+
Weave together the evidence into a coherent narrative:
|
| 241 |
+
- Mechanism of Action: How does the intervention work?
|
| 242 |
+
- Clinical Evidence: What do the trials show? Be specific about effect sizes.
|
| 243 |
+
- Comparative Evidence: How does it compare to alternatives?
|
| 244 |
+
|
| 245 |
+
### Recommendations (REQUIRED - 3-5 bullet points)
|
| 246 |
+
Provide actionable clinical recommendations based on the evidence.
|
| 247 |
+
|
| 248 |
+
### Limitations (REQUIRED - 1 paragraph)
|
| 249 |
+
Acknowledge gaps, biases, and areas needing more research.
|
| 250 |
+
|
| 251 |
+
### References (REQUIRED)
|
| 252 |
+
List the key references in proper academic format.
|
| 253 |
+
|
| 254 |
+
## CRITICAL RULES
|
| 255 |
+
1. ONLY cite papers from the provided evidence - NEVER hallucinate references
|
| 256 |
+
2. Write in complete sentences and paragraphs
|
| 257 |
+
3. Avoid lists/bullets except in Recommendations section
|
| 258 |
+
4. Include specific statistics when available (p-values, effect sizes, CIs)
|
| 259 |
+
5. Acknowledge uncertainty honestly
|
| 260 |
+
"""
|
| 261 |
+
```
|
| 262 |
+
|
| 263 |
+
#### 3. Updated Orchestrator Integration
|
| 264 |
+
|
| 265 |
+
```python
|
| 266 |
+
# In src/orchestrators/simple.py
|
| 267 |
+
|
| 268 |
+
async def _generate_synthesis(
|
| 269 |
+
self,
|
| 270 |
+
query: str,
|
| 271 |
+
evidence: list[Evidence],
|
| 272 |
+
assessment: JudgeAssessment,
|
| 273 |
+
) -> str:
|
| 274 |
+
"""Generate narrative synthesis using LLM."""
|
| 275 |
+
from src.agents.synthesis import SynthesisAgent
|
| 276 |
+
|
| 277 |
+
synthesis_agent = SynthesisAgent(domain=self.domain)
|
| 278 |
+
|
| 279 |
+
report = await synthesis_agent.synthesize(
|
| 280 |
+
query=query,
|
| 281 |
+
evidence=evidence,
|
| 282 |
+
assessment=assessment,
|
| 283 |
+
domain=self.domain,
|
| 284 |
+
)
|
| 285 |
+
|
| 286 |
+
return report.to_markdown()
|
| 287 |
+
```
|
| 288 |
+
|
| 289 |
+
### Few-Shot Example (Required for Quality)
|
| 290 |
+
|
| 291 |
+
From issue #82, include a concrete example in the prompt:
|
| 292 |
+
|
| 293 |
+
```python
|
| 294 |
+
FEW_SHOT_EXAMPLE = """
|
| 295 |
+
## Example: Strong Evidence Synthesis
|
| 296 |
+
|
| 297 |
+
INPUT:
|
| 298 |
+
- Query: "Alprostadil for erectile dysfunction"
|
| 299 |
+
- Evidence: 15 papers including meta-analysis of 8 RCTs (N=3,247)
|
| 300 |
+
- Mechanism Score: 9/10
|
| 301 |
+
- Clinical Score: 9/10
|
| 302 |
+
|
| 303 |
+
OUTPUT:
|
| 304 |
+
|
| 305 |
+
### Executive Summary
|
| 306 |
+
|
| 307 |
+
Alprostadil (prostaglandin E1) represents a well-established second-line treatment
|
| 308 |
+
for erectile dysfunction, with meta-analytic evidence demonstrating 87% efficacy
|
| 309 |
+
in achieving erections sufficient for intercourse. It offers a PDE5-independent
|
| 310 |
+
mechanism particularly valuable for patients who do not respond to oral therapies.
|
| 311 |
+
|
| 312 |
+
### Background
|
| 313 |
+
|
| 314 |
+
Erectile dysfunction affects approximately 30 million men in the United States,
|
| 315 |
+
with prevalence increasing with age. While PDE5 inhibitors (sildenafil, tadalafil)
|
| 316 |
+
remain first-line therapy, approximately 30% of patients are non-responders or
|
| 317 |
+
have contraindications. Alprostadil provides an alternative mechanism of action
|
| 318 |
+
through direct smooth muscle relaxation.
|
| 319 |
+
|
| 320 |
+
### Evidence Synthesis
|
| 321 |
+
|
| 322 |
+
**Mechanism of Action**
|
| 323 |
+
|
| 324 |
+
Alprostadil works through a distinct pathway from PDE5 inhibitors. It binds to
|
| 325 |
+
EP receptors on cavernosal smooth muscle, activating adenylate cyclase and
|
| 326 |
+
increasing intracellular cAMP. This leads to smooth muscle relaxation and
|
| 327 |
+
penile erection independent of nitric oxide signaling. As noted by Smith et al.
|
| 328 |
+
(2019), this mechanism explains its efficacy in patients with endothelial
|
| 329 |
+
dysfunction or nerve damage.
|
| 330 |
+
|
| 331 |
+
**Clinical Evidence**
|
| 332 |
+
|
| 333 |
+
A meta-analysis by Johnson et al. (2020) pooled data from 8 randomized controlled
|
| 334 |
+
trials (N=3,247) comparing intracavernosal alprostadil to placebo. The primary
|
| 335 |
+
endpoint of erection sufficient for intercourse was achieved in 87% of alprostadil
|
| 336 |
+
patients versus 12% placebo (RR 7.25, 95% CI: 5.8-9.1, p<0.001). The number
|
| 337 |
+
needed to treat (NNT) was 1.3, indicating robust effect size.
|
| 338 |
+
|
| 339 |
+
Subgroup analysis revealed consistent efficacy across etiologies:
|
| 340 |
+
- Vascular ED: 85% response rate
|
| 341 |
+
- Neurogenic ED: 91% response rate
|
| 342 |
+
- Post-prostatectomy: 82% response rate
|
| 343 |
+
|
| 344 |
+
### Recommendations
|
| 345 |
+
|
| 346 |
+
1. Consider alprostadil as second-line therapy when PDE5 inhibitors fail or are contraindicated
|
| 347 |
+
2. Start with 10 μg intracavernosal injection, titrate up to 40 μg based on response
|
| 348 |
+
3. Provide in-office training for self-injection technique
|
| 349 |
+
4. Monitor for penile fibrosis with long-term use (occurs in 3-5% of patients)
|
| 350 |
+
|
| 351 |
+
### Limitations
|
| 352 |
+
|
| 353 |
+
Long-term data beyond 2 years is limited. Head-to-head comparisons with
|
| 354 |
+
newer therapies (low-intensity shockwave) are lacking. Most trials excluded
|
| 355 |
+
patients with severe cardiovascular disease, limiting generalizability.
|
| 356 |
+
The intraurethral formulation (MUSE) has lower efficacy (43%) than injection.
|
| 357 |
+
|
| 358 |
+
### References
|
| 359 |
+
|
| 360 |
+
1. Smith AB et al. (2019). Alprostadil mechanism of action in erectile tissue.
|
| 361 |
+
J Urol. https://pubmed.ncbi.nlm.nih.gov/12345678/
|
| 362 |
+
2. Johnson CD et al. (2020). Meta-analysis of intracavernosal alprostadil.
|
| 363 |
+
J Sex Med. https://pubmed.ncbi.nlm.nih.gov/23456789/
|
| 364 |
+
"""
|
| 365 |
+
```
|
| 366 |
+
|
| 367 |
+
## Implementation Plan
|
| 368 |
+
|
| 369 |
+
### Phase 1: Core SynthesisAgent
|
| 370 |
+
|
| 371 |
+
1. Create `src/agents/synthesis.py` with:
|
| 372 |
+
- `SynthesisAgent` class
|
| 373 |
+
- `NarrativeReport` Pydantic model
|
| 374 |
+
- LLM-based synthesis method
|
| 375 |
+
|
| 376 |
+
2. Create `src/prompts/synthesis.py` with:
|
| 377 |
+
- `SYNTHESIS_SYSTEM_PROMPT`
|
| 378 |
+
- `FEW_SHOT_EXAMPLE`
|
| 379 |
+
- `format_synthesis_context()` helper
|
| 380 |
+
|
| 381 |
+
3. Update `src/orchestrators/simple.py`:
|
| 382 |
+
- Make `_generate_synthesis()` async
|
| 383 |
+
- Call `SynthesisAgent.synthesize()`
|
| 384 |
+
- Keep `_generate_partial_synthesis()` as fallback (free tier)
|
| 385 |
+
|
| 386 |
+
### Phase 2: Advanced Mode Integration
|
| 387 |
+
|
| 388 |
+
4. Update `src/orchestrators/advanced.py`:
|
| 389 |
+
- Add `SynthesisAgent` to Magentic workflow
|
| 390 |
+
- Ensure it receives all evidence from prior agents
|
| 391 |
+
|
| 392 |
+
### Phase 3: Test Coverage
|
| 393 |
+
|
| 394 |
+
5. Create `tests/unit/agents/test_synthesis.py`:
|
| 395 |
+
- Test narrative output structure
|
| 396 |
+
- Test reference accuracy (no hallucinated citations)
|
| 397 |
+
- Test prose vs bullet point ratio
|
| 398 |
+
|
| 399 |
+
### Phase 4: Domain Customization
|
| 400 |
+
|
| 401 |
+
6. Update `src/config/domain.py`:
|
| 402 |
+
- Add `synthesis_system_prompt` field to `DomainConfig`
|
| 403 |
+
- Add `synthesis_few_shot_example` field
|
| 404 |
+
- Configure for sexual health domain
|
| 405 |
+
|
| 406 |
+
## File Changes
|
| 407 |
+
|
| 408 |
+
| File | Change |
|
| 409 |
+
|------|--------|
|
| 410 |
+
| `src/agents/synthesis.py` | NEW - SynthesisAgent |
|
| 411 |
+
| `src/prompts/synthesis.py` | NEW - Synthesis prompts |
|
| 412 |
+
| `src/orchestrators/simple.py` | MODIFY - Call SynthesisAgent |
|
| 413 |
+
| `src/orchestrators/advanced.py` | MODIFY - Add to Magentic |
|
| 414 |
+
| `src/config/domain.py` | MODIFY - Add synthesis prompts |
|
| 415 |
+
| `src/utils/models.py` | MODIFY - Add NarrativeReport |
|
| 416 |
+
| `tests/unit/agents/test_synthesis.py` | NEW - Tests |
|
| 417 |
+
| `tests/unit/prompts/test_synthesis.py` | NEW - Tests |
|
| 418 |
+
|
| 419 |
+
## Acceptance Criteria
|
| 420 |
+
|
| 421 |
+
- [ ] Report contains **paragraph-form prose**, not just bullet points
|
| 422 |
+
- [ ] Report has **executive summary** (2-3 sentences)
|
| 423 |
+
- [ ] Report has **background section** explaining the condition
|
| 424 |
+
- [ ] Report has **synthesized narrative** weaving evidence together
|
| 425 |
+
- [ ] Report has **actionable recommendations**
|
| 426 |
+
- [ ] Report has **limitations** section (honest acknowledgment)
|
| 427 |
+
- [ ] Citations are **properly formatted** (author, year, title, URL)
|
| 428 |
+
- [ ] No hallucinated references (CRITICAL)
|
| 429 |
+
- [ ] Works in both simple and advanced modes
|
| 430 |
+
- [ ] Falls back gracefully on free tier (minimal templating OK)
|
| 431 |
+
|
| 432 |
+
## Test Criteria
|
| 433 |
+
|
| 434 |
+
```python
|
| 435 |
+
def test_report_is_narrative_not_bullets():
|
| 436 |
+
"""Report should be mostly prose, not bullet points."""
|
| 437 |
+
report = synthesis_agent.synthesize(...)
|
| 438 |
+
|
| 439 |
+
# Count paragraphs vs bullet points
|
| 440 |
+
paragraphs = len([p for p in report.split('\n\n') if len(p) > 100])
|
| 441 |
+
bullets = report.count('\n- ')
|
| 442 |
+
|
| 443 |
+
# Prose should dominate
|
| 444 |
+
assert paragraphs > bullets, "Report should be narrative, not bullet list"
|
| 445 |
+
|
| 446 |
+
def test_references_not_hallucinated():
|
| 447 |
+
"""All references must come from provided evidence."""
|
| 448 |
+
evidence_urls = {e.citation.url for e in evidence}
|
| 449 |
+
report = synthesis_agent.synthesize(...)
|
| 450 |
+
|
| 451 |
+
for ref in report.references:
|
| 452 |
+
assert ref.url in evidence_urls, f"Hallucinated reference: {ref.url}"
|
| 453 |
+
```
|
| 454 |
+
|
| 455 |
+
## Related Microsoft Agent Framework Patterns
|
| 456 |
+
|
| 457 |
+
| Pattern | Location | Application |
|
| 458 |
+
|---------|----------|-------------|
|
| 459 |
+
| Custom Aggregator | `concurrent_custom_aggregator.py` | LLM-based synthesis |
|
| 460 |
+
| Fan-Out/Fan-In | `fan_out_fan_in_edges.py` | Multi-expert synthesis |
|
| 461 |
+
| Research Assistant | `research_assistant_agent.py` | Tool-based research |
|
| 462 |
+
| Sequential Orchestration | `spec-001-foundry-sdk-alignment.md` | Analyst→Writer→Editor chain |
|
| 463 |
+
|
| 464 |
+
## References
|
| 465 |
+
|
| 466 |
+
- GitHub Issue #85: Report lacks narrative synthesis
|
| 467 |
+
- GitHub Issue #86: Microsoft Agent Framework patterns
|
| 468 |
+
- LangChain Deep Agents blog: Few-shot examples importance
|
| 469 |
+
- Open Deep Research Architecture: Scoping + Synthesis pattern
|